Financial Architects, Inc Catalyst Biosciences, Inc. Transaction History

Financial Architects, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$7.08 - $10.6 $7,788 - $11,660	-1,100 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$7.67 - $9.96 $8,437 - $10,956	1,100 New	1,100 $9,000
Q1 2019 May 03, 2019	SELL	$7.67 - $9.96 $8,437 - $10,956	-1,100 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$6.59 - $11.28 $3,295 - $5,640	-500 Reduced 31.25%	1,100 $9,000
Q3 2018 Oct 29, 2018	BUY	$9.35 - $12.44 $7,480 - $9,952	800 Added 100.0%	1,600 $17,000
Q2 2018 Aug 03, 2018	BUY	$9.11 - $28.88 $1,822 - $5,776	200 Added 33.33%	800 $9,000
Q1 2018 Apr 23, 2018	BUY	$14.18 - $35.6 $8,508 - $21,360	600 New	600 $15,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.